OA
LLY icon

Oracle Alpha’s Eli Lilly LLY Stock Holding History

Oracle Alpha’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$833K Sell
1,071
-489
-31% -$348K 1.49% 3
2023
Q4 		$909K Buy
+1,560
New +$911K 1.18% 5

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Oracle Alpha's LLY Position: Q1 2024 in Review

Oracle Alpha reduced its Eli Lilly (LLY) stake by 31% in Q1 2024, selling an estimated $348K and leaving 1,071 shares worth $833K. The position accounts for 1.49% of the portfolio, ranked #3.

Oracle Alpha first reported a position in LLY in Q4 2023 and has held it in 2 quarters since. The position peaked at $909K in Q4 2023. 3,461 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Oracle Alpha held 1,071 shares of Eli Lilly worth $833K as of Q1 2024.
  • Oracle Alpha sold 489 Eli Lilly shares in Q1 2024, an estimated $348K.
  • Eli Lilly made up 1.49% of Oracle Alpha's portfolio in Q1 2024, its #3 holding.
  • Oracle Alpha first reported a position in Eli Lilly in Q4 2023 and has held it in 2 quarters since.
  • Oracle Alpha's Eli Lilly position peaked at $909K in Q4 2023.
  • 3,461 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Oracle Alpha's 13F filing for Q1 2024, filed 15 May 2024.